Compositions pharmaceutiques anticonvulsives

作者: Jammoul Firas , Caroline Coriat , José Alain Sahel , Serge Picaud , Manuel Simonutti

DOI:

关键词:

摘要: La presente invention concerne l'utilisation d'une substance selectionnee parmi le groupe comprenant la taurine, un precurseur de metabolite derive analogue taurine et une requise pour biosynthese fabrication composition pharmaceutique destinee a prevenir ou inhiber les effets secondaires indesirables causes organisme humain animal par principe actif qui induit niveau eleve d'acide gamma-amino butyrique (GABA) extracellulaire renforce l'activation du recepteur GABA.

参考文章(4)
E L Berson, S Y Schmidt, C Huang, G Watson, Retinal degeneration in cats fed casein. III. Taurine deficiency and ERG amplitudes. Investigative Ophthalmology & Visual Science. ,vol. 16, pp. 673- 678 ,(1977)
E Anyanwu, G.F.A Harding, The involvement of taurine in the action mechanism of sodium valproate (VPA) in the treatment of epilepsy. Acta Physiologica, Pharmacologica et Therapeutica Latinoamericana : Organo de la Asociacion Latinoamericana de Ciencias Fisiologicas y [de] la Asociacion Latinoamericana de Farmacologia. ,vol. 43, pp. 20- 27 ,(1993)
V Yu Smirnov, Yu E Razvodovskii, EM Doroshenko, None, Metabolic Effects of Mixture Containing Branched-Chain Amino Acids and Taurine during Subchronic Poisoning with Barbiturates Bulletin of Experimental Biology and Medicine. ,vol. 137, pp. 443- 446 ,(2004) , 10.1023/B:BEBM.0000038148.22505.B3
Jörg Mühling, Marie E. Campos, Armin Sablotzki, Matthias Krüll, Marius G. Dehne, Jens Gonther, Stefan Weiss, Markus Fuchs, Gunter Hempelmann, Effects of propofol and taurine on intracellular free amino acid profiles and immune function markers in neutrophils in vitro. Clinical Chemistry and Laboratory Medicine. ,vol. 40, pp. 111- 121 ,(2002) , 10.1515/CCLM.2002.020